Yoram Drucker
Chairman chez NUREXONE BIOLOGIC INC.
Fortune : 7 M $ au 31/03/2024
Profil
Mr. Yoram N.
Drucker is a Chairman & Vice President-Strategic Operations at NurExone Biologic, Inc. He is on the Board of Directors at NurExone Biologic Ltd.
and I.R-Med Ltd.
Mr. Drucker was previously employed as a CEO, President, Secretary, Treasurer & Director by Revium Recovery, Inc., a Director & VP-Business Development by IR-Med, Inc., a Director & Vice President-Business Development by InnoCan Pharma Corp., an Independent Director by Cell Source, Inc., a Chairman by Cell Source Ltd., a Chief Executive Officer & Chairman by Rainbow Energy Ltd., a Chief Executive Officer by Virucure Ltd., a Secretary, Chief Executive & Operating Officer by Brainstorm Cell Therapeutics, Inc., and a Vice President-Business Development by Millennium Electric T.O.U.
Ltd.
He also served on the board at Pluristem Ltd.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
IR-MED INC
5,79% | 01/04/2024 | 4 050 000 ( 5,79% ) | 5 M $ | 31/03/2024 |
NUREXONE BIOLOGIC INC
5,84% | 18/05/2023 | 3 230 000 ( 5,84% ) | 2 M $ | 31/03/2024 |
Postes actifs de Yoram Drucker
| Sociétés | Poste | Début |
|---|---|---|
| NUREXONE BIOLOGIC INC. | Chairman | 01/01/2020 |
I.R-Med Ltd.
 I.R-Med Ltd. Electronic Equipment/InstrumentsElectronic Technology I.R-Med Ltd. is a medical device company specializing in infrared light-based diagnostics. The company was founded by Ronnie Klein on September 27, 2012 and is headquartered in Rosh Pinna, Israel. | Director/Board Member | - |
NurExone Biologic Ltd.
 NurExone Biologic Ltd. Pharmaceuticals: MajorHealth Technology Part of NurExone Biologic, Inc., NurExone Biologic Ltd. is an Israeli company that offers a new approach to Spinal Cord Injury treatment. The private company is based in Bnei-Brak, Israel. The company believes that intranasal exosome administration offers an alternative to cell transplantation. The company was founded in 2020 by Yoram Nathan Drucker. Lior Shaltiel has been the CEO of the company since 2021. NurExone Biologic was acquired by EnerSpar Corp. on June 15, 2022. | Founder | 01/05/2020 |
Anciens postes connus de Yoram Drucker
| Sociétés | Poste | Fin |
|---|---|---|
| IR-MED INC. | Director/Board Member | 27/03/2024 |
| CELL SOURCE, INC. | Chairman | 19/08/2015 |
Cell Source Ltd.
 Cell Source Ltd. BiotechnologyHealth Technology Part of Cell Source, Inc., Cell Source Ltd. develops cell therapy treatments. The private company is based in Tel Aviv, Israel. The Israeli company was founded by Yoram Nathan Drucker. Cell Source was acquired by Cell Source, Inc. on June 30, 2014 for $15.97 million. | Chief Executive Officer | 01/10/2013 |
| Rainbow Energy Ltd. | Chief Executive Officer | 01/09/2011 |
| Virucure Ltd. | Chief Executive Officer | 02/01/2007 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 6 |
|---|---|
| BRAINSTORM CELL THERAPEUTICS INC. | Health Technology |
| CELL SOURCE, INC. | Health Technology |
| REVIUM RECOVERY INC. | Distribution Services |
| INNOCAN PHARMA CORPORATION | Health Technology |
| IR-MED INC. | Health Technology |
| NUREXONE BIOLOGIC INC. | Health Technology |
| Entreprise privées | 7 |
|---|---|
Cell Source Ltd.
Cell Source Ltd. BiotechnologyHealth Technology Part of Cell Source, Inc., Cell Source Ltd. develops cell therapy treatments. The private company is based in Tel Aviv, Israel. The Israeli company was founded by Yoram Nathan Drucker. Cell Source was acquired by Cell Source, Inc. on June 30, 2014 for $15.97 million. | Health Technology |
Pluristem Ltd.
 Pluristem Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Pluri, Inc., Pluristem Ltd. is an Israeli company that sources therapeutic cells from the placenta to create cell-based products for commercial use. The private company is based in Haifa, Israel and was founded by Yoram Nathan Drucker. The company's patented and validated 3D cell expansion system is designed to mimic the human body, and its cell therapies have potentially groundbreaking applications for treating ischemia, damaged muscle, hematology deficiencies, and inflammation. Pluristem's method is uniquely accurate, cost-effective, and consistent from batch to batch. Pluristem was acquired by Pluri, Inc. on June 23, 2003. | Commercial Services |
Millennium Electric T.O.U. Ltd.
 Millennium Electric T.O.U. Ltd. Building ProductsProducer Manufacturing Millennium Electric T.O.U. Ltd. engages in PV and PVT solar technologies field. It develops, produces and sells solar electricity from Photovoltaic (PV) panels, solar PV applications, and the Multi Solar System. Millennium’s Main Market Activities: Planning, construction and maintenance of Solar PV Power stations (turn key projects) for supplying electricity using solar energy, Production and sale of Solar Photovoltaic (PV) Panels (under the Millennium brand name), from 10 watts and up to 300 watts, Production and sale of Multi Solar Systems and Collectors PVT (MSS collectors), Planning, production and sale of various solar PV applications for infrastructures, lighting and more, and R&D for the future solar technologies. Millennium Electric T.O.U. has representatives in the U.S.A., Africa and Europe. The company was founded by Ami Elazari on March 18, 1999 and is headquartered in Raanana, Israel. | Producer Manufacturing |
| Rainbow Energy Ltd. | |
I.R-Med Ltd.
I.R-Med Ltd. Electronic Equipment/InstrumentsElectronic Technology I.R-Med Ltd. is a medical device company specializing in infrared light-based diagnostics. The company was founded by Ronnie Klein on September 27, 2012 and is headquartered in Rosh Pinna, Israel. | Electronic Technology |
| Virucure Ltd. | |
NurExone Biologic Ltd.
NurExone Biologic Ltd. Pharmaceuticals: MajorHealth Technology Part of NurExone Biologic, Inc., NurExone Biologic Ltd. is an Israeli company that offers a new approach to Spinal Cord Injury treatment. The private company is based in Bnei-Brak, Israel. The company believes that intranasal exosome administration offers an alternative to cell transplantation. The company was founded in 2020 by Yoram Nathan Drucker. Lior Shaltiel has been the CEO of the company since 2021. NurExone Biologic was acquired by EnerSpar Corp. on June 15, 2022. | Health Technology |
